Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of Glivec (imatinib mesylate) in patients with advanced neuroblastoma
2005-005778-63Phase 2Completed
- Sponsor
- Istituto Giannina Gaslini
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in neuroblastoma, sponsored by Istituto Giannina Gaslini. Started Sep 2007; status: completed.
02
Drugs
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on 2005-005778-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005778-63.